Atossa Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €143.68M +34.0% €41.53M -1,237.6% 28.9% +0.32 pp N/A N/A
    (estimated) €107.20M +∞% -€3.65M -92.0% -3.4% -0.034 pp N/A N/A
    (estimated) €0.00 +NaN% -€45.50M +39.0% N/A N/A N/A
    (estimated) €0.00 +NaN% -€32.74M +20.4% N/A N/A N/A
    (estimated) €0.00 +NaN% -€27.20M +25.0% N/A N/A N/A
    €0.00 +NaN% -€21.75M -15.3% N/A -€17.92M +100,301.4% N/A
    €0.00 +NaN% -€25.67M +14.7% N/A -€17.85K -99.9% N/A
    €0.00 +NaN% -€22.37M +27.3% N/A -€17.68M +25.9% N/A
    €0.00 +NaN% -€17.58M -2.3% N/A -€14.04M +42.4% N/A
    €0.00 +NaN% -€18.00M +22.4% N/A -€9.86M +26.8% N/A
    €0.00 +NaN% -€14.70M +51.2% N/A -€7.78M +3.1% N/A
    €0.00 +NaN% -€9.73M +40.4% N/A -€7.55M +34.2% N/A
    €0.00 +NaN% -€6.93M +27.5% N/A -€5.62M +22.9% N/A
    €0.00 -100.0% -€5.43M -59.6% N/A -€4.58M -61.2% N/A
    €1.50K -99.7% -€13.44M +7.5% -896,491.6% -8.9K pp -€11.79M +35.4% -786,266.3% -7.8K pp
    €448.61K -16.9% -€12.50M +35.9% -2,786.9% -11 pp -€8.71M +22.4% -1,941.7% -6.2 pp
    €539.54K +31.3% -€9.20M +112.3% -1,704.9% -6.5 pp -€7.11M +121.5% -1,318.5% -5.4 pp
    €410.99K +32,022.8% -€4.33M +47.6% -1,054.3% +2.3K pp -€3.21M +12.2% -781.5% +2.2K pp
    €1.28K +∞% -€2.94M +216.7% -229,484.6% -2.3K pp -€2.86M +837.0% -223,695.5% -2.2K pp
    €0.00 -€927.10K N/A -€305.45K N/A

    Notifications